As a leading referral center for pediatric inflammatory bowel disease (IBD), the mission of our center is to offer our patients the finest quality of health care available.
To uphold this mission, our center is also committed to discovering the causes of, and improving the treatments for, Crohn’s disease and ulcerative colitis.
Clinical and Translational Investigation
Basic Research and IBD Center Laboratories
Our Ongoing Research
We are currently investigating many areas to try to identify causes and improve diagnosis and treatment of Crohn's disease and ulcerative colitis, including:
View a table of all of our current studies.
- Understanding the basis for inflammatory bowel disease and developing efficient therapies for young children with Crohn's disease and ulcerative colitis.
- Determining how bacteria affect the intestines of IBD patients
- Determining how the immune systems of patients with IBD are unique
- Discovering new, noninvasive ways of diagnosing, treating, and assessing disease activity in Crohn's disease and ulcerative colitis.
- Determining if specific gene-environment triggers can be identified by studying unaffected siblings of patients with Crohn's disease.
- Investigating how infliximab and antibody levels affect remission rates and loss of response in patients with inflammatory bowel disease who receive(d) this treatment.
- Studying bone mineral density in IBD and the use of calcitonin in treating low bone density.
- Further understanding the health outcomes of our patients through both clinical data and analyses of samples.
- Following new patients with ulcerative colitis and studying how they respond to a standardized treatment regiment.
- Improving the clinical outcomes of pediatric patients with inflammatory bowel disease through collaboration with other centers across the United States.
- Understanding how out patients are caring for themselves as they go through life and grow up with inflammatory bowel disease.